维普中文期刊产品整合服务
70篇 您的检索式:作者名="Trigo C"
    题名 作者 年代 出处 被引量
1A multicenter phase Ⅱ trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patientswith previously treated metastatic breast cancer 显示文摘MILLER K D TRIGO J M WHEELER C 2005Clin Cancer Res2005,11,9:1
2Activity of glycolytic enzymes in the gut of Hormogaster elisae(Oligechaeta Hormogastridae)显示文摘GARVIN M H LATTAUD C TRIGO D 2000Soil Biology & Biochemistry2000,,32:1
3Activity of glycolytic enzymes in the gut of Hormogaster elisae (O1- igechaeta Hormogastridae) 显示文摘GARVIN M H LATI'AUD C TRIGO D 2000Soil Biol Biochem2000,32,:1
4Activity of glycolyticenzymes in the gut of Hormogaster elisae (OligechaetaHormogastridae) 显示文摘Gavin M H Lattaud C Trigo D 2000Soil Biology & Biochemistry2000,,92:1
5Start-up of the Anammox process in a membrane bioreactor 显示文摘Trigo C Campos J L Garrido J M 2006Journal of Biotechnology2006,126,4:1
6Mutualism and biodiversity in soils显示文摘LAVELLE P Lattaud C Trigo D 1995Plant Soil1995,170,:1
7Start-up of the anammox process in a membrane bioreactor显示文摘Trigo C Campos J L Garrido J M 0,,04:1
8A multicenter phase Ⅱ trial of ZD6474,a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor,in patients with previously treated metastatic breast cancer显示文摘Miller KD Trigo JM Wheeler C 0,,09:1
9A multicenter phase Ⅱ trial of ZD6474, a vascular endothelial growth factor receptor - 2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer显示文摘Miller KD Trigo JM Wheeler C 2005Clin Cancer Res2005,11,:1
10A multicenter phase Ⅱ trial of Vandetanib,a vascμLar endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor,in patients with previously treated metastatic breast cancer显示文摘Miller KD Trigo JM Wheeter C 0,,:1
11A multicenter phase Utrial of ZD6474,a vascular endothelial growth factor receptor and epidermal growt h factor receptor tyrosine kinase inhibitor,in patients with previously treated metastatic breast cancer显示文摘Miler KD Trigo JM Wheeler C 2005Clin Cancer Res2005,65,11:1
12Maize and resistant starch enriched breads reduce postprandial glycemic responses in rats显示文摘C M Brites M J Trigo B Carrapico 2011Nutrition Research2011,31,4:1
13A multicenter phase U trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer显示文摘Miler KD Trigo JM Wheeler C 2005Clin Cancer Res2005,11,:1
14A muhicenter phase Ⅱ trial of ZD6474, a vascular endothelial growth factor re- ceptor-2 and epidermal growth factor receptor tyrosine kinase in- hibitor, in patients with previously treated Metastatic breast canc- er 显示文摘MILLER KD TRIGO JM WHEELER C 2005Clin Cancer Res2005,11,9:1
15Start-up of the ANAMMOX process in a membrane bioreactor显示文摘TRIGO C CAMPOS J L GARRIDO J M 2006Biotechnology2006,126,:1
16Start-up of the Anammox process in a membrane bioreactor 显示文摘Trigo C Campos J L Garrido J M 2006Journal of Biotechnology2006,126,4:1
17Synthesis and Electrochemical Performance of Anode Material NiO 显示文摘Morant C Soriano L Trigo J F 1998Thin Solid Films1998,317,:1
18Start-up of the Anammox process in a membrane bioreactor显示文摘TRIGO C CAMPOS J L GARRIDO J M 2006Journal of Biotechnology2006,126,47:1
19Optimisation of the Preventive Maintenance Plan of a Series Components System 显示文摘Duarte J A C Craveiro J C T A Trigo T P 2006International Journal of Pressure Vessels and Piping2006,83,4:1
20Start-up of the Anammox process in a membrane bioreactor 显示文摘Trigo C Campos J L Garrido J M 2006Journal of Biotechnology2006,126,4:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费